Item 2.02 Results of Operations and Financial Condition.

On November 12, 2012, Transcept Pharmaceuticals, Inc. issued a press release relating to its financial results for the three and nine months ended September 30, 2012 and certain other information and held a conference call to discuss its financial results for the quarter ended September 30, 2012. A transcript containing relevant excerpts from that conference call is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

The following Exhibit is filed as part of this Current Report on Form 8-K.

(d) Exhibits

Exhibit Number Description

99.1 Transcript of November 12, 2012 conference call.

---